ClinicalTrials.Veeva

Menu

Antihypertensive Effect of Fermented Milk With Lactococcus Lactis on Prehypertensive Subjects

C

Centro de Investigación en Alimentación y Desarrollo A.C.

Status

Completed

Conditions

Hypertension

Treatments

Dietary Supplement: Acidified milk
Dietary Supplement: Fermented milk

Study type

Interventional

Funder types

Other

Identifiers

NCT02670811
VAGB 001

Details and patient eligibility

About

The objective of the present work was to evaluate the antihypertensive effect associated with the consumption of fermented milk with Lactococcus lactis NRRL-B50571 on prehypertensive subjects.

Full description

A double-blind randomized controlled clinical study of an 8-week intervention with 36 hypertensive subjects was carried out to evaluate the antihypertensive effect of fermented milk with Lactococcus lactis NRRL-B50571. Once obtained the informed consent; volunteers were randomized into two groups (n=18) to either receive 150 mL daily: fermented milk with Lactococcus lactis NRRL-B50571 (intervention group) or artificially acidified milk as control (placebo). Both drinks were consumed daily. Participants were asked not to change their diet or lifestyle during the intervention. We applied intention to treat for those participants who did not have good adherence and those who withdraw the study. The outcomes between groups were analyzed using an independent sample Student t test, with a P value of 0.05 or less (two sided) when there was statistical significance; using statistical software.

Enrollment

36 patients

Sex

All

Ages

25 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Systolic blood pressure >130 mmHg
  • Diastolic blood pressure > 85 mmHg

Exclusion criteria

  • Pregnant women
  • Cardiovascular diseases
  • Diabetes
  • Cancer
  • Dairy allergy
  • Lactose intolerance
  • Patients receiving angiotensin converting enzyme inhibitors as pharmacological therapy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

36 participants in 2 patient groups, including a placebo group

Intervention
Experimental group
Description:
Daily consumption of 150 mL of fermented milk with Lactococcus lactis for 8 weeks
Treatment:
Dietary Supplement: Fermented milk
Placebo
Placebo Comparator group
Description:
Daily consumption of 150 mL of artificially acidified milk
Treatment:
Dietary Supplement: Acidified milk

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems